Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.44 |
| ▸ | CDC25B | P30305 | 5/20 | 0.42 |
| ▸ | GJB2 | P29033 | 2/20 | 0.42 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.40 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.40 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9009910 | 0.88 | NT5E (0.51) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL8055010 | 0.88 | NT5E (0.51) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL8055015 | 0.88 | NT5E (0.51) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL19731881 | 0.86 | PTPN1 (0.40) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL19731818 | 0.85 | NT5E (0.44) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL12099744 | 0.84 | NT5E (0.49) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL25913950 | 0.84 | LMNA (0.54) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL22677699 | 0.83 | SSTR1 (0.57) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL22678415 | 0.83 | SSTR1 (0.57) | PTPN1NT5EPTPN2PTPN11CDC25B | |
| SCHEMBL22677692 | 0.83 | SSTR1 (0.57) | PTPN1NT5EPTPN2PTPN11CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336784-B2 | Methods for modular synthesis of N-glycans and arrays thereof | ACADEMIA SINICA (TW) | 2019-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336784-B2 | Methods for modular synthesis of N-glycans and arrays thereof | SIGLEC7, SIGLEC9, CD4 | PTPN1 185/4885NT5E 314/4885PTPN2 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.